After the Fed released minutes of its last meeting, the bond market signaled it fears the Fed will not be aggressive enough with its rate cutting.Market Insiderread more
The Fed minutes also note that "a couple" members wanted a 50 basis point cut, based primarily on the weak inflation readings.The Fedread more
The inversion is seen by many veteran traders as an important recession omen, though the timing on the eventual downturn is less predictable.Bondsread more
Here's what Nordstrom reported for its fiscal second-quarter earnings.Retailread more
The sexy image that once boosted Victoria's Secret has been haunting L Brands more recently, as women are steering clear of the brand's hot pink, lacy and bejeweled lingerie.Retailread more
See which stocks are posting big moves after the bell.Market Insiderread more
"I'd love to say that the optimistic universe is most likely to prevail, but the talking heads talk endlessly about how a recession is inevitable," CNBC's Jim Cramer says.Mad Money with Jim Cramerread more
Read the fine print in your Apple Card contract — one clause means you give up your right to be heard in court.Technologyread more
Federal Reserve members worried over future growth are highly concerned about the U.S.-China tariff battleThe Fedread more
President Donald Trump signed a memorandum on Wednesday to automatically cancel the student loan debt of disabled veterans. More than 25,000 service members will have their...Personal Financeread more
Jim Nussle, a former director of the Office of Management and Budget, told CNBC on Wednesday that a strong U.S. consumer is the only thing keeping the country from recession.Marketsread more
Roku Inc.: "I don't feel like I have any real right to opine on Roku. I just don't feel like I do, because I thought it was expensive in the $40s and $50s and here it is at $70. It's gotten away from me. I'm not the call on Roku."
Crispr Therapeutics AG: "I don't want to put it in a college fund, it's a 'mad money' idea, but a younger person should be thinking just about something like Crispr. It's very speculative. Swiss company. I do like it, though."
Oneok Inc.: "There isn't any bad news on it. I think it's a buy. I really like that. I think it's a very good yield equivalent. It's a really good fixed income play right here. It's come down a lot."
Prudential Financial Inc.: "How the heck is that stock down 15 percent? That's a good company. [CEO John] Strangfeld's doing a really good job. 3.7 percent yield. I'm going to endorse that."
Iqiyi Inc.: "I'm recommending no Chinese stock right now. I don't like the way the PRC is trying to pop up stocks. And, by the way, if the president looked at all of the junk that they're issuing on the New York Stock Exchange, I think what the president would say is, 'You know what? Hey, China, until you get your act together, we don't want your IPOs.' But that would involve a kind of big chain of think[ing] there, you know."
Transenterix Inc.: "I'm familiar with it, but there is no 'next ISRG' as long as there is ISRG, which I saw was running today. They solved a big patent issue. Just keep buying ISRG. That's the one to do. "